Mindray Announces Appointment of Three Members to Its Executive Team
SHENZHEN, China, June 12, 2013
SHENZHEN, China, June 12, 2013 /PRNewswire/ --Mindray Medical International
Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical
devices worldwide, today announced that the company has appointed Mr. Cheng
Minghe to be co-Chief Executive Officer (co-CEO). Mr. Cheng is currently the
company's Chief Strategic Officer and will maintain this role. Mr.Li Xiting,
Mindray's President and CEO, will now be President and co-CEO and will remain
the company's director of the board.
The company has also appointed Mr. Wang Jianxin to be Chief Administrative
Officer and Ms. May Li to be Chief Investment Officer. Mr. Wang was previously
Vice President of Mindray and Ms. Li was previously the Deputy CFO. All
appointments will take effect immediately.
In Mr. Cheng's new role, he will assist Mr. Li in executing the company's
strategies and overseeing its operations. As a co-founder of Mindray, Mr.
Cheng has served in various roles across sales, marketing and strategic
development since the company's establishment in 1991. Mr. Cheng received his
bachelor's and master's degrees in biomedical engineering from Shanghai
"I am very excited about Mr. Cheng's appointment as the co-CEO," commented Mr.
Li. "His extensive experience and exceptional leadership skills made him an
ideal candidate for this role. I look forward to him joining me in fulfilling
our company's vision and mission in the future."
"I am very honored to be entrusted with this opportunity and look forward to
my new role in implementing Mindray's growth strategies," added Mr. Cheng. "I
will work very closely with Mr. Li on future ventures in order to take the
company to the next level."
In Mr. Wang's new role, he will be responsible for China sales, marketing,
research and development, and some other operations. Mr. Wang has served in
the company for more than six years in public relations. He previously held
executive roles in the private and public sectors. He received his master's
degree in Management Science and Engineering from Harbin University of Science
and Technology, and his bachelor's degree in Automation from the University of
Shanghai for Science and Technology.
In Ms. Li's new role, her responsibilities will include corporate finance,
investor relations and strategic development. Ms. Li has served the company
for more than five years in various roles across investor relations, finance
and strategic development. Ms. Li worked in financial communications and sales
management prior to joining Mindray. She received her bachelor's degree in
Sociology from Peking University.
We are a leading developer, manufacturer and marketer of medical devices
worldwide. We maintain our global headquarters in Shenzhen, China, U.S.
headquarters in Mahwah, New Jersey and multiple sales offices in major
international markets. From our main manufacturing and engineering base in
China, we supply through our worldwide distribution network a broad range of
products across three primary business segments, namely patient monitoring and
life support, in-vitro diagnostic, and medical imaging systems. For more
information, please visit http://ir.mindray.com.
For investor and media inquiries, please contact:
In the U.S:
Western Bridge, LLC
Mindray Medical International Limited
SOURCE Mindray Medical International Limited
Press spacebar to pause and continue. Press esc to stop.